Detalhe da pesquisa
1.
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial.
Lancet
; 402(10405): 871-881, 2023 09 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37478883
2.
Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non-small cell lung cancer.
Cancer
; 129(17): 2685-2693, 2023 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37129197
3.
Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors.
Invest New Drugs
; 34(3): 290-9, 2016 06.
Artigo
Inglês
| MEDLINE | ID: mdl-26961907
4.
Integration of Remote Symptom and Biometric Monitoring Into the Care of Adult Patients With Cancer Receiving Chemotherapy-A Decentralized Feasibility Pilot Study.
JCO Oncol Pract
; 19(6): e811-e821, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36821818
5.
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy.
J Clin Oncol
; 41(15): 2682-2690, 2023 May 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37196429
6.
Brief Report: Clinical Response, Toxicity, and Resistance Mechanisms to Osimertinib Plus MET Inhibitors in Patients With EGFR-Mutant MET-Amplified NSCLC.
JTO Clin Res Rep
; 4(8): 100533, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37649681
7.
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial.
Nat Med
; 29(3): 593-604, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36928818
8.
Poziotinib for Patients With HER2 Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II Trial.
J Clin Oncol
; 40(7): 702-709, 2022 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34550757
9.
Phase I Trial of Definitive Concurrent Chemoradiotherapy and Trametinib for KRAS-Mutated Non-Small Cell Lung Cancer.
Cancer Treat Res Commun
; 30: 100514, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35051703
10.
Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivity.
Cancer Cell
; 40(7): 754-767.e6, 2022 07 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35820397
11.
Toxicity and Survival After Intensity-Modulated Proton Therapy Versus Passive Scattering Proton Therapy for NSCLC.
J Thorac Oncol
; 16(2): 269-277, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33198942
12.
High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial.
Radiother Oncol
; 162: 60-67, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34237343
13.
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial.
Nat Med
; 27(3): 504-514, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33603241
14.
A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung Cancer.
Clin Cancer Res
; 26(14): 3525-3536, 2020 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32193228
15.
Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC.
J Thorac Oncol
; 15(9): 1449-1459, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32389639
16.
Phase II Trial of Cediranib in Combination With Cisplatin and Pemetrexed in Chemotherapy-Naïve Patients With Unresectable Malignant Pleural Mesothelioma (SWOG S0905).
J Clin Oncol
; 37(28): 2537-2547, 2019 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31386610
17.
Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study.
Int J Radiat Oncol Biol Phys
; 100(3): 730-737, 2018 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29248169
18.
Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer.
Ann Thorac Surg
; 105(2): 418-424, 2018 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-29217088
19.
Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer.
J Clin Oncol
; 36(18): 1813-1822, 2018 06 20.
Artigo
Inglês
| MEDLINE | ID: mdl-29293386
20.
Response rates to single-agent chemotherapy after exposure to immune checkpoint inhibitors in advanced non-small cell lung cancer.
Lung Cancer
; 112: 90-95, 2017 10.
Artigo
Inglês
| MEDLINE | ID: mdl-29191606